However, as only one study examined the risk of PCP prophylaxis discontinuation at different CD4 strata, including ≤100 cells/μL, it may not be appropriate to apply this recommendation to individuals with CD4 counts of ≤100 cells/μL at this time. Here, CD4 is linked to pneumocystosis.